UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Dec

    23

    UCB Announces FDA Acceptance of BLA Resubmission for Bimekizumab

    Read More

    Dec

    13

    Employee Spotlight: Leah VanderVeen and Her Time as a Court Appointed Special Advocate for Foster Children

    Read More

    Dec

    07

    The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis

    Read More

    Nov

    22

    UCB Submits Response to FDA Complete Response Letter for Bimekizumab

    Read More

    Nov

    14

    UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients

    Read More

    Sep

    26

    UCB U.S. Headquarters in Atlanta Awarded Prestigious LEED Gold WELL Platinum Certifications

    Read More

    Sep

    26

    UCB Achieves Two Awards Recognizing our Sustainability Efforts for the Atlanta Warehouse Expansion

    Read More

    Sep

    22

    UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting

    Read More

    Aug

    17

    UCB Partners in Health Economics and Outcomes Research to Evolve Solutions for Seizure Clusters

    Read More

    Aug

    16

    How Winners of the UCB Family Epilepsy Scholarship Prepare to Go Back to School

    As students and parents prepare for a new school year, there can be a lot of stress  – from meeting new teachers and preparing for classes, to financial assistance and making new friends. For people living with epilepsy and their caregivers, the stress and worry surrounding back-to-school preparation is compounded.

    Read More

    © 2009 - 2026 UCB, Inc. Atlanta. All rights reserved. 
    Last updated: March 2026